Journal
HUMAN GENE THERAPY
Volume 20, Issue 5, Pages 453-464Publisher
MARY ANN LIEBERT INC
DOI: 10.1089/hum.2008.172
Keywords
-
Categories
Funding
- Italian Association for Cancer Research (Milan, Italy)
- Italian Ministry for Education, University, and Research
- University of Bologna (Bologna, Italy)
- AlmaMedicina Foundation (Bologna, Italy)
- Pallotti Funds, Department of Experimental Pathology, University of Bologna
- Italian Foundation for Cancer Research (Milan, Italy)
- University of Bologna
- W. Vanini-S. Cavagnino Foundation, Interdepartmental Centre for Cancer Research, University of Bologna
Ask authors/readers for more resources
The highly aggressive cancer syndrome of female mice carrying a p53 knockout allele and a rat HER-2/neu (Neu) transgene (BALB-p53Neu) can be prevented by a cell vaccine presenting three components: Neu, interleukin (IL)-12 production, and allogeneic major histocompatibility complex (MHC) alleles (Triplex cell vaccine). Here we tested a second-generation Triplex DNA-based vaccine (Tri-DNA), consisting of the combination of three gene components (a transmembrane -extracellular domain fragment of the Neu gene, IL-12 genes, and the H-2D(q) allogeneic MHC gene), carried by separate plasmids. The Tri-DNA vaccine was at least as effective as the Triplex cell vaccine for cancer immunoprevention, giving a similar delay in the onset of mammary cancer and complete protection from salivary cancer. Both vaccines induced anti-Neu antibodies of the murine IgG2a isotype at similar levels. The Tri-DNA vaccine gave more restricted immunostimulation, consisting of a fully helper T cell type 1 (Th1)-polarized response, with effective production of interferon (IFN)-gamma in response to the vaccine but no spontaneous production, and no induction of anti-Neu IgG3 antibodies. On the other hand, the Triplex cell vaccine induced both Th1 and Th2 cytokines, a strong increase in spontaneous IFN-gamma production, and high levels of IgG3 antibodies recognizing Neu-positive syngeneic cells. In conclusion, the Tri-DNA vaccine is as effective as Triplex cell vaccine, exploiting a more restricted immune stimulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available